Results for tag: "Biotech Royalties"

The Biotech Royalties market is a subset of the biotechnology industry that focuses on the sale and licensing of intellectual property rights related to biotechnology products. These products can include pharmaceuticals, medical devices, diagnostics, and agricultural products. Companies in the market typically acquire or develop intellectual property rights and then license them to other companies for a fee. This fee is known as a royalty and is typically based on a percentage of the licensee’s sales. The Biotech Royalties market is a key source of revenue for biotechnology companies, allowing them to fund research and development of new products. Notable companies in the Biotech Royalties market include AbbVie, Amgen, AstraZeneca, Bayer, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more